In CML patients with BCR-ABL translocation, deregulation of two lncRNAs has been described: the Beta Globin Locus 3 (BGL3) lncRNA [172] and the imprinted H19 lncRNA [173]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.